Clinical Trial Update: Patients With Renal Impairment Undergoing CT [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining outcomes for patients with renal impairment undergoing CT with contrast, focusing on contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Contrast Induced Nephropathy | Phase 4 | Status: COMPLETED